Terms: = Gastric cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
33 results:
1. Total Versus Subtotal Gastrectomy for Distal gastric Poorly Cohesive Carcinoma.
Boubaddi M; Teixeira Farinha H; Lambert C; Pereira B; Piessen G; Gualtierotti M; Voron T; Mantziari S; Pezet D; Gronnier C;
Ann Surg Oncol; 2024 Feb; 31(2):744-752. PubMed ID: 37971616
[TBL] [Abstract] [Full Text] [Related]
2. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
Janjigian YY; Kawazoe A; Bai Y; Xu J; Lonardi S; Metges JP; Yanez P; Wyrwicz LS; Shen L; Ostapenko Y; Bilici M; Chung HC; Shitara K; Qin SK; Van Cutsem E; Tabernero J; Li K; Shih CS; Bhagia P; Rha SY;
Lancet; 2023 Dec; 402(10418):2197-2208. PubMed ID: 37871604
[TBL] [Abstract] [Full Text] [Related]
3. Predictive Value of a Radiomics Nomogram Model Based on Contrast-Enhanced Computed Tomography for KIT Exon 9 Gene Mutation in Gastrointestinal Stromal Tumors.
Wei Y; Lu Z; Ren Y
Technol Cancer Res Treat; 2023; 22():15330338231181260. PubMed ID: 37296525
[TBL] [Abstract] [Full Text] [Related]
4. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.
Chang J; Wu H; Wu J; Liu M; Zhang W; Hu Y; Zhang X; Xu J; Li L; Yu P; Zhu J
J Transl Med; 2023 Mar; 21(1):191. PubMed ID: 36915111
[TBL] [Abstract] [Full Text] [Related]
5. Spectral CT-based nomogram for preoperative prediction of perineural invasion in locally advanced gastric cancer: a prospective study.
Li J; Xu S; Wang Y; Fang M; Ma F; Xu C; Li H
Eur Radiol; 2023 Jul; 33(7):5172-5183. PubMed ID: 36826503
[TBL] [Abstract] [Full Text] [Related]
6. Risk of Lymph Node Metastasis in T1b gastric cancer: An International Comprehensive Analysis from the Global gastric Group (G3) Alliance.
Vos EL; Nakauchi M; Gönen M; Castellanos JA; Biondi A; Coit DG; Dikken JL; D'ugo D; Hartgrink H; Li P; Nishimura M; Schattner M; Song KY; Tang LH; Uyama I; Vardhana S; Verhoeven RHA; Wijnhoven BPL; Strong VE
Ann Surg; 2023 Feb; 277(2):e339-e345. PubMed ID: 34913904
[TBL] [Abstract] [Full Text] [Related]
7. Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real-world evidence study.
Liu JM; Wu CT; Hsu RJ; Hsu WL
Cancer Med; 2021 Nov; 10(22):8162-8171. PubMed ID: 34590436
[TBL] [Abstract] [Full Text] [Related]
8. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
[No Abstract] [Full Text] [Related]
9. Expression and prognosis analyses of BUB1, bub1b and BUB3 in human sarcoma.
Long Z; Wu T; Tian Q; Carlson LA; Wang W; Wu G
Aging (Albany NY); 2021 Apr; 13(9):12395-12409. PubMed ID: 33872216
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of Lymph Node Metastasis in Patients With gastric cancer to Identify Those Suitable for Middle Segmental Gastrectomy.
Khalayleh H; Kim YW; Yoon HM; Ryu KW
JAMA Netw Open; 2021 Mar; 4(3):e211840. PubMed ID: 33729506
[TBL] [Abstract] [Full Text] [Related]
11. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
12. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract] [Full Text] [Related]
13. Lutetium oxodotreotide (
Smith-Palmer J; Leeuwenkamp OR; Virk J; Reed N
BMC Cancer; 2021 Jan; 21(1):10. PubMed ID: 33402120
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced gastric cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Shitara K; Van Cutsem E; Bang YJ; Fuchs C; Wyrwicz L; Lee KW; Kudaba I; Garrido M; Chung HC; Lee J; Castro HR; Mansoor W; Braghiroli MI; Karaseva N; Caglevic C; Villanueva L; Goekkurt E; Satake H; Enzinger P; Alsina M; Benson A; Chao J; Ko AH; Wainberg ZA; Kher U; Shah S; Kang SP; Tabernero J
JAMA Oncol; 2020 Oct; 6(10):1571-1580. PubMed ID: 32880601
[TBL] [Abstract] [Full Text] [Related]
15. gastric Adenocarcinoma in a Moroccan Population: First Report on Survival Data.
Lahmidani N; Miry S; Abid H; El Yousfi M; Benajah D; Ibrahimi A; El Abkari M; Najdi A
Gulf J Oncolog; 2019 Sep; 1(31):36-40. PubMed ID: 31591989
[TBL] [Abstract] [Full Text] [Related]
16. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract] [Full Text] [Related]
17. Effects of metastasectomy and other factors on survival of patients with ovarian metastases from gastric cancer: a systematic review and meta-analysis.
Zhang C; Hou W; Huang J; Yin S; Wang P; Zhang Z; Tan Y; Xu H
J Cell Biochem; 2019 Sep; 120(9):14486-14498. PubMed ID: 31050365
[TBL] [Abstract] [Full Text] [Related]
18. Comparable rates of lymph node metastasis and survival between diffuse type and intestinal type early gastric cancer patients: a large population-based study.
Li ZY; Zhang QW; Teng LM; Zhang CH; Huang Y
Gastrointest Endosc; 2019 Jul; 90(1):84-95.e10. PubMed ID: 30885598
[TBL] [Abstract] [Full Text] [Related]
19. The clinical outcomes of S-1 plus cisplatin for patients with advanced gastric cancer: A meta-analysis and systematic review.
Yang L; Wang X; Wang B; Chao P; Li D; Chai C
Medicine (Baltimore); 2018 Dec; 97(49):e12789. PubMed ID: 30544367
[TBL] [Abstract] [Full Text] [Related]
20. Identification of discrepancy between CTLA4 expression and CTLA4 activation in gastric cancer.
Xiang Z; Chen W; Zhang J; Song S; Xia GK; Huang XY; Xie J; Yu Y; Zhang QY
Immunopharmacol Immunotoxicol; 2019 Jun; 41(3):386-393. PubMed ID: 30422018
[No Abstract] [Full Text] [Related]
[Next]
